If you liked this article you might like

European Pharma Shares Hammered After Trump Press Conference Attack
Nasdaq Hits Records Even as Crude Selloff Sours Rest of Market
Takeda Pays $5.2 Billion for Leukemia Drug Maker Ariad, Ending Months of Takeout Speculation